Dr. Ken Savin
Chief Scientific Officer
Redwire
After receiving his PhD from the University of Utah in synthetic organic chemistry, Dr Kenneth Savin did a post doc at the Memorial Sloan Kettering Cancer Center before going on to work for Eli Lilly and Co. as a senior research scientist. During his 20-year career in the pharmaceutical industry, Ken led discovery chemistry research teams, discovery operations, radiochemistry, drug disposition, chemistry development and product teams as well as being an adjunct faculty member at Butler University.
During the last four years of Ken’s industrial career, he led an effort that resulted in five separate flight experiments flown on the International Space Station. After retiring from Lilly, he joined the team at the Center for the Advancement of Science In Space (CASIS) (the operators of the International Space Station US National Lab) working in both Business Development, as a science lead and ultimately as the Sr. Director of In Space Production Applications. During his time at CASIS, Ken worked with a team at NASA to develop the In Space Production and Applications program that is run out of NASA as an effort to develop products in space that will benefit life on the Earth. Ken joined the Redwire team in early 2022 to be the Chief Scientific Officer at Redwire. His focus at Redwire has been on the commercialization of work performed in the labs at Redwire and in developing partnerships that will lead to better products and easier access to the value that space based products can have to humanity.
Related Sessions
Game Changers Track
Wednesday, April 10, 2024
9:00 am - 5:00 pm
Track: Track Program